Lithium Ion

Lithium Ion

SCHEMBL2182209

CCNC(=O)Nc1nc2c(F)c(-c3ccc(C(=O)N4CCCC(C(=O)[O-])C4)cc3)cc(-c3ncccc3F)c2s1.[Li+]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.37
▸ NTRK1 P04629 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ POLB P06746 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CCNK O75909 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ CCNH P51946 1/20 0.34
▸ MNAT1 P51948 1/20 0.34
▸ CDK12 Q9NYV4 1/20 0.34
▸ JAK1 P23458 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium SCHEMBL2182213 0.93 NTRK1 (0.39) ALDH1A1NTRK1L3MBTL1LMNAHTT
SCHEMBL2182204 0.93 NTRK1 (0.39) ALDH1A1NTRK1L3MBTL1LMNAHTT
SCHEMBL2180817 0.91 HPGD (0.45) ALDH1A1LMNAPOLBKDM4E
Lithium Ion SCHEMBL2180645 0.90 ALDH1A1 (0.38) ALDH1A1NTRK1LMNAHTTPOLB
SCHEMBL1843124 0.85 RIPK1 (0.43) L3MBTL1KDM4ECDK2
SCHEMBL2180642 0.83 MAP3K12 (0.39) ALDH1A1NTRK1LMNAHTTPOLB
Lithium SCHEMBL2180652 0.83 MAP3K12 (0.39) ALDH1A1NTRK1LMNAHTTPOLB
SCHEMBL2181076 0.81 TP53 (0.47) ALDH1A1LMNAKDM4E
SCHEMBL1843498 0.81 ABL1 (0.42) —
SCHEMBL1841408 0.79 ABL1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US claimed
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS TOP2B, TOP1, POLI ALDH1A1 2009/4885NTRK1 3890/4885L3MBTL1 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback